ArticleAnnals of surgical oncology2026
Practice Patterns and Overall Survival for Octogenarians with Triple Negative Breast Cancer Treated at Accredited Cancer Centers in the USA.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe purpose of this study was to examine treatment patterns and overall survival (OS) for patients ≥ 80 years with triple negative breast cancer (TNBC). PATIENTS AND
methodsThe National Cancer Data Base was queried for patients ≥ 80 years old diagnosed with TNBC from 2012 to 2022. Patients with T1a or Tis tumors or distant metastatic disease were excluded. Charlson-Deyo comorbidity scores were used to assess comorbidity burden. Treatment patterns of chemotherapy, radiation therapy, and surgery were examined. OS was estimated using Kaplan-Meier curves and multivariable Cox proportional hazards models evaluated factors associated with OS.
resultsIn total, 10,767 patients met inclusion criteria: 5876 (54.5%) were aged 80-84 years, 3296 (30.6%) were 85-89, and 1595 (14.8%) were ≥ 90. Most patients had a Charlson-Deyo score of 0 (69.53%), while 565 patients (5.25%) had scores ≥ 3. Surgery alone was performed in 6916 (64.23%) patients, while 2584 (24.0%) underwent surgery plus chemotherapy, 811 (7.5%) received no treatment, and 284 (2.63%) received chemotherapy alone. Regional lymph nodes were tumor positive in 3001 patients (27.87%). On multivariable analysis, surgery (HR 0.36; 95% CI 0.32-0.41, p < 0.0001) and surgery plus chemotherapy (HR 0.23; 95% CI 0.20-0.27, p < 0.0001) were associated with improved OS when compared with no treatment. At 2.5 years of follow-up, OS was 22.2% for patients who received no treatment, 69.5% for surgery, and 77.6% for surgery plus chemotherapy.
conclusionsSurgical management of TNBC in octogenarians is associated with improved OS, with the greatest survival seen in patients undergoing surgery and chemotherapy. These findings are not causal but demonstrate that some octogenarians derive survival benefit from surgery and systemic treatment.
Indexed as
Identifiers
42429900What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.